SCHEMBL2371310

SCHEMBL2371310

O=C(O)C1SCCS1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1643614 0.97
SCHEMBL313459 0.88
Hydrochloric Acid SCHEMBL9845878 0.85 FAAH (0.44)
SCHEMBL9784243 0.80
SCHEMBL5180257 0.73
SCHEMBL5180663 0.71
SCHEMBL7238912 0.71
SCHEMBL1643611 0.69
SCHEMBL17359980 0.69
SCHEMBL17359978 0.67 SUCNR1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2547322-A2 USE OF NITROCARBOXYLIC ACIDS FOR THE TREATMENT, DIAGNOSIS AND PROPHYLAXIS OF AGGRESSIVE HEALING PATTERNS Dietz, Ulrich (DE) 2013-01-23 EP claimed
WO-2011113507-A2 USE OF NITROCARBOXYLIC ACIDS FOR THE TREATMENT, DIAGNOSIS AND PROPHYLAXIS OF AGGRESSIVE HEALING PATTERNS DIETZ ULRICH (DE) 2011-09-22 WO claimed
EP-0743574-B1 Migration imaging members XEROX CORP (US) 2000-12-27 EP claimed
EP-0743573-B1 Method for obtaining image contrast migration imaging members XEROX CORP (US) 2000-09-06 EP claimed
EP-0190900-A2 Cephalosporin compounds, their production, and pharmaceutical compositions containing them YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1986-08-13 EP claimed
WO-2025047358-A1 ELECTROLYTIC CAPACITOR AND ADDITIVE FOR LIQUID COMPONENT OF ELECTROLYTIC CAPACITOR パナソニックIPマネジメント株式会社 2025-03-06 WO disclosed
US-20210373002-A1 METHOD FOR ORGANIZING INDIVIDUAL MOLECULES ON A PATTERNED SUBSTRATE AND STRUCTURES ASSEMBLED THEREBY UNIVERSITY OF BRITISH COLUMBIA (CA) 2021-12-02 US disclosed
US-11129784-B2 Shaping keratin fibres using oxoethanoic acid and/or derivatives thereof THE PROCTER AND GAMBLE COMPANY (US) 2021-09-28 US disclosed
US-11125748-B2 Method for organizing individual molecules on a patterned substrate and structures assembled thereby UNIVERSITY OF BRITISH COLUMBIA (CA) 2021-09-21 US disclosed
US-10945931-B2 Shaping keratin fibres using dialdehyde compounds THE PROCTER AND GAMBLE COMPANY (US) 2021-03-16 US disclosed
US-10912726-B2 Shaping keratin fibres using a reducing composition and a fixing composition THE PROCTER AND GAMBLE COMPANY (US) 2021-02-09 US disclosed
US-10568826-B2 Shaping keratin fibres using a pretreatment and a protein crosslinking composition THE PROCTER AND GAMBLE COMPANY (US) 2020-02-25 US disclosed
US-5189158-A 4-SUBSTITUTED AZETIDINONES AS PRECURSORS TO 2-SUBSTITUTED-3-CARBOXY CARBAPENEM ANTIBIOTICS AND A METHOD OF PRODUCING THEM AMERICAN CYANAMID COMPANY (US) 1993-02-23 US disclosed
CN-1065061-A Novel 4-substituted azetidinones as precursors to 2-substituted-3-carboxycarbapenem antibiotics and processes for their preparation AMERICAN CYANAMID CO (US) 1992-10-07 CN disclosed
EP-0504612-A2 Novel 4-substituted azetidinones as precursors to 2-substituted-3-carboxy carbapenem antibiotics and a method of producing them AMERICAN CYANAMID COMPANY (US) 1992-09-23 EP disclosed
US-4973704-A ANTICHOLESTEROL AGENTS SANDOZ PHARM. CORP. (US) 1990-11-27 US disclosed
US-4851427-A INHJIBITORS OF CHOLESTEROL BIOSYNTHESIS SANDOZ PHARM. CORP. (US) 1989-07-25 US disclosed
EP-0190900-A2 Cephalosporin compounds, their production, and pharmaceutical compositions containing them YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1986-08-13 EP disclosed
US-4225589-A ANTITUMOR RHONE-POULENC INDUSTRIES (FR) 1980-09-30 US disclosed
US-3947469-A PROSTAGLANDIN INTERMEDIATES RECHERCHE ET INDUSTRIE THERAPEUTIQUES (R.I.T.) (BE) 1976-03-30 US disclosed